-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Abeona Therapeutics, Lowers Price Target to $18

Benzinga·11/12/2026 12:26:06
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Abeona Therapeutics (NASDAQ:ABEO) with a Buy and lowers the price target from $20 to $18.